Page last updated: 2024-08-17

methionine and n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea

methionine has been researched along with n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barthomeuf, C; Cellarier, E; Chollet, P; D'Incan, M; Demidem, A; Durando, X; Farges, MC; Thivat, E; Vasson, MP	1
Demidem, A; Guénin, S; Morvan, D; Stepien, G; Thivat, E	1
Bacin, F; Cellarier, E; Chollet, P; D'Incan, M; Durando, X; Farges, MC; Madelmont, JC; Mouret-Reynier, MA; Thivat, E; Vasson, MP	1

Trials

2 trial(s) available for methionine and n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea

Article	Year
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial. Nutrition and cancer, 2008, Volume: 60, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Melanoma; Methionine; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Nutritional Status; Oligodendroglioma; Patient Compliance; Treatment Outcome	2008
Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diet; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Melanoma; Methionine; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Nutritional Status; Prognosis; Survival Rate; Treatment Outcome	2009

Article

Year

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.

Nutrition and cancer, 2008, Volume: 60, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Melanoma; Methionine; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Nutritional Status; Oligodendroglioma; Patient Compliance; Treatment Outcome

2008

Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma.

Anticancer research, 2009, Volume: 29, Issue:12

Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diet; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Melanoma; Methionine; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Nutritional Status; Prognosis; Survival Rate; Treatment Outcome

2009

Other Studies

1 other study(ies) available for methionine and n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea

Article	Year
Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming. Nutrition and cancer, 2009, Volume: 61, Issue:4 Topics: Adaptation, Physiological; Analysis of Variance; Animals; Antineoplastic Agents; Body Weight; Cell Proliferation; Combined Modality Therapy; Confidence Intervals; Growth Inhibitors; Liver; Male; Melanoma, Experimental; Metabolome; Methionine; Mice; Mice, Inbred C57BL; Nitrosourea Compounds; Nuclear Magnetic Resonance, Biomolecular; Organ Size; Phosphatidylethanolamine N-Methyltransferase; Phospholipids; Random Allocation; Stress, Physiological; Time Factors; Tumor Burden	2009

Article

Year

Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.

Nutrition and cancer, 2009, Volume: 61, Issue:4

Topics: Adaptation, Physiological; Analysis of Variance; Animals; Antineoplastic Agents; Body Weight; Cell Proliferation; Combined Modality Therapy; Confidence Intervals; Growth Inhibitors; Liver; Male; Melanoma, Experimental; Metabolome; Methionine; Mice; Mice, Inbred C57BL; Nitrosourea Compounds; Nuclear Magnetic Resonance, Biomolecular; Organ Size; Phosphatidylethanolamine N-Methyltransferase; Phospholipids; Random Allocation; Stress, Physiological; Time Factors; Tumor Burden

2009